Publicaciones en colaboración con investigadores/as de Centro de Investigación Príncipe Felipe (12)

2024

  1. Novel insight into the lipid network of plasma extracellular vesicles reveal sex-based differences in the lipidomic profile of alcohol use disorder patients

    Biology of Sex Differences, Vol. 15, Núm. 1

2023

  1. Lipidomic landscape of circulating extracellular vesicles isolated from adolescents exposed to ethanol intoxication: a sex difference study

    Biology of Sex Differences, Vol. 14, Núm. 1

2020

  1. Circulating micrornas in extracellular vesicles as potential biomarkers of alcohol-induced neuroinflammation in adolescence: gender differences

    International Journal of Molecular Sciences, Vol. 21, Núm. 18, pp. 1-16

2019

  1. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)

    European Journal of Immunology, Vol. 49, Núm. 10, pp. 1457-1973

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2015

  1. GOBLET: The Global Organisation for Bioinformatics Learning, Education and Training

    PLoS Computational Biology, Vol. 11, Núm. 4

2014

  1. The activation of the Sox2 RR2 pluripotency transcriptional reporter in human breast cancer cell lines is dynamic and labels cells with higher tumorigenic potential

    Frontiers in Oncology, Vol. 4, Núm. NOV

2012

  1. Guidelines for the use and interpretation of assays for monitoring autophagy

    Autophagy, Vol. 8, Núm. 4, pp. 445-544

2011

  1. RasGrf1 deficiency delays dging in mice

    Aging, Vol. 3, Núm. 3, pp. 262-276

  2. Transcriptional repression of the tumor suppressor DRO1 by AIB1

    FEBS Letters, Vol. 585, Núm. 19, pp. 3041-3046

2003

  1. Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects

    Human Mutation, Vol. 22, Núm. 4, pp. 301-312